U.S.-listed shares of Teva Pharmaceutical fell after the company reported Q4 results and gave poor 2019 outlook. Fred Katayama reports.
Peoples are using these keywords: Blockbuster multiple sclerosis drug copaxone, Blockbuster multiple sclerosis drug copaxonekare schultz, Healthcare, Pills, New migraine treatment ajovy, Worlds largest generic drugmaker, Teva, Teva pharmaceutical industries, Kare schultz

You might also like this


Please enter your comment!
Please enter your name here